BIAF
bioAffinity Technologies, Inc.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$6.71M
P/E Ratio
—
EPS
$-4.67
Beta
-1.33
52W High
$13.80
52W Low
$0.69
50-Day MA
$2.26
200-Day MA
$2.48
Dividend Yield
—
Profit Margin
-280.60%
Forward P/E
—
PEG Ratio
—
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
Fundamentals
| Revenue (TTM) | $5.66M |
| Gross Profit (TTM) | $1.87M |
| EBITDA | $-11.10M |
| Operating Margin | -267.60% |
| Return on Equity | -623.00% |
| Return on Assets | -107.10% |
| Revenue/Share (TTM) | $2.09 |
| Book Value | $0.81 |
| Price-to-Book | 1.83 |
| Price-to-Sales (TTM) | 1.19 |
| EV/Revenue | 0.891 |
| EV/EBITDA | -0.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -27.10% |
| Shares Outstanding | $4.53M |
| Float | $4.42M |
| % Insiders | 3.17% |
| % Institutions | 9.06% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
More HEALTHCARE Stocks
Data last updated: 6/13/2026